title: Targeting lipogenesis blocks adaptation to antiangiogenic therapy.
abstract: Adaptation to antiangiogenic therapy withdrawal involves a metabolic shift to de novo lipogenesis.
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D008055:Lipids / Q000096:biosynthesis*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D008055:Lipids